Trades on 3 secondary markets

Aspen Neuroscience

Aspen Neuroscience is a clinical-stage biotechnology company developing personalized regenerative cell therapies for Parkinson's disease. Its lead candidate, ANPD001, is an autologous induced pluripotent stem cell (iPSC)-derived neuron replacement therapy that uses a patient's own cells to restore d

minimal 8.8 / 100 0 APIs View provider profile →

Company Life Sciences Biotechnology Cell Therapy Regenerative Medicine Neuroscience

Aspen Neuroscience is an API provider whose private shares are listed on 3 secondary markets: Forge Global, Hiive, EquityZen.

Where It Trades

F Forge Global View listing → H Hiive View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.